Long-Term Evaluation of Effectiveness and Immunological Implications of Ocrelizumab in a Real-World Cohort
Abstract Background and Objectives Extended follow-up data from real-world cohorts of patients with multiple sclerosis treated with ocrelizumab (OCR) are becoming widely available. This monocentric retrospective study aimed to evaluate the long-term effectiveness of OCR and its impact on immunoglobu...
Saved in:
| Main Authors: | Tommaso Guerra, Francesca Caputo, Antonella Bianco, Damiano Paolicelli, Pietro Iaffaldano |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-03-01
|
| Series: | Drugs - Real World Outcomes |
| Online Access: | https://doi.org/10.1007/s40801-025-00486-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany
by: Mathias Buttmann, et al.
Published: (2025-05-01) -
Real-World Persistence with Ocrelizumab in Multiple Sclerosis: a Systematic Review
by: John L. Petrie, et al.
Published: (2024-10-01) -
Real-world experience of ocrelizumab in multiple sclerosis patients in Latin America
by: Juan Ignacio ROJAS, et al.
Published: (2021-06-01) -
The protective role of cognitive reserve in moderating depressive symptomatology in patients with multiple sclerosis
by: Madia M. Biasi, et al.
Published: (2025-07-01) -
Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III program.
by: Paul Emery, et al.
Published: (2014-01-01)